Target Name: RASSF6
NCBI ID: G166824
Review Report on RASSF6 Target / Biomarker Content of Review Report on RASSF6 Target / Biomarker
RASSF6
Other Name(s): Ras association domain family member 6 | Ras association (RalGDS/AF-6) domain family 6 | Putative RAS binding protein | Ras association domain family member 6, transcript variant 1 | RASF6_HUMAN | Ras association (RalGDS/AF-6) domain family member 6 | putative RAS binding protein | Ras association domain family member 6, transcript variant 2 | Ras association domain-containing protein 6 (isoform b) | RASSF6 variant 1 | RASSF6 variant 2 | Ras association domain-containing protein 6 (isoform a) | DKFZp686K23225 | Ras association domain-containing protein 6

RASSF6: A Drug Target / Disease Biomarker

RNA-associated protein 6 (RASSF6) is a protein that is expressed in various tissues and cells throughout the body. It is a member of the RASSF6 gene family, which encodes a protein that is involved in the regulation of RNA translation efficiency. RASSF6 is also known as UTR6 and has been shown to play a role in the regulation of various cellular processes, including cell growth, differentiation, and metabolism.

One of the key functions of RASSF6 is its role in the regulation of translation efficiency, which is the process by which RNA polymerase uses information in the DNA template to produce proteins. RASSF6 is known to play a role in the recognition and cleavage of specific mRNAs by the translation machinery, which is the complex of RNA polymerase, ribosome, and transfer factors that is responsible for producing proteins from mRNAs.

In addition to its role in translation efficiency, RASSF6 is also involved in the regulation of cell growth and differentiation. It has been shown to play a role in the regulation of cell proliferation and the establishment of cell lineage, as well as in the regulation of cell survival and apoptosis.

RASSF6 is also involved in the regulation of metabolism and energy homeostasis. It has been shown to play a role in the regulation of glucose metabolism and the production of fatty acids, as well as in the regulation of lipid metabolism.

Despite its involvement in a wide range of cellular processes, RASSF6 is not well understood, and much of its function and regulation remains to be defined. There are currently several research studies focused on RASSF6, with a focus on its role as a drug target or biomarker.

One of the main areas of research on RASSF6 is its potential as a drug target. RASSF6 has been shown to play a role in the regulation of cellular processes that are important for the development and progression of cancer, as well as for the regulation of inflammation and fibrosis. Several studies have shown that inhibiting RASSF6 can lead to the inhibition of these processes and the regression of cancer growth or the improvement of therapeutic outcomes in animal models of cancer.

Another area of research on RASSF6 is its potential as a biomarker. Several studies have shown that RASSF6 can be used as a biomarker for various diseases, including cancer, cardiovascular disease, and neurological disorders. The expression of RASSF6 has been shown to be altered in a wide range of diseases, and its levels have been used as a biomarker for the diagnosis and prognosis of these diseases.

Overall, RASSF6 is a protein that is involved in a wide range of cellular processes and has the potential to be a drug target or biomarker. Further research is needed to fully understand its function and regulation and to develop effective therapies based on these insights.

Protein Name: Ras Association Domain Family Member 6

Functions: Involved in the induction of apoptosis, through both caspase-dependent and caspase-independent pathways. May act as a Ras effector protein. May suppress the serum-induced basal levels of NF-kappa-B (By similarity)

The "RASSF6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RASSF6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RASSF7 | RASSF8 | RASSF8-AS1 | RASSF9 | RAVER1 | RAVER2 | RAX | RAX2 | RB1 | RB1-DT | RB1CC1 | RBAK | RBAK-RBAKDN | RBAKDN | RBBP4 | RBBP4P2 | RBBP4P6 | RBBP5 | RBBP6 | RBBP7 | RBBP8 | RBBP8NL | RBBP9 | RBCK1 | RBFA | RBFOX1 | RBFOX2 | RBFOX3 | RBIS | RBKS | RBL1 | RBL2 | RBM10 | RBM11 | RBM12 | RBM12B | RBM14 | RBM14-RBM4 | RBM15 | RBM15-AS1 | RBM15B | RBM17 | RBM17P1 | RBM18 | RBM19 | RBM20 | RBM22 | RBM22P1 | RBM23 | RBM24 | RBM25 | RBM26 | RBM26-AS1 | RBM27 | RBM28 | RBM3 | RBM33 | RBM34 | RBM38 | RBM39 | RBM4 | RBM41 | RBM42 | RBM43 | RBM43P1 | RBM44 | RBM45 | RBM46 | RBM47 | RBM48 | RBM48P1 | RBM4B | RBM5 | RBM5-AS1 | RBM6 | RBM7 | RBM8A | RBMS1 | RBMS1P1 | RBMS2 | RBMS2P1 | RBMS3 | RBMS3-AS3 | RBMX | RBMX2 | RBMX2P1 | RBMXL1 | RBMXL2 | RBMXL3 | RBMY1A1 | RBMY1B | RBMY1D | RBMY1F | RBMY1J | RBMY2EP | RBMY2FP | RBP1 | RBP2 | RBP3 | RBP4